DCM
MRNA icon

Davidson Capital Management’s Moderna MRNA Stock Holding History

Davidson Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$5.33K – 99
2024
Q1 		$5.33K Buy
+50
New +$5.04K ﹤0.01% 93
2023
Q4 		– Sell
-46
Closed -$4.75K – 122
2023
Q3 		$4.75K Buy
46
+18
+64% +$2.01K ﹤0.01% 76
2023
Q2 		$3.4K Buy
28
+8
+40% +$1.07K ﹤0.01% 82
2023
Q1 		$3.07K Sell
20
-1
-5% -$165 ﹤0.01% 82
2022
Q4 		$3.77K Buy
21
+4
+24% +$654 ﹤0.01% 71
2022
Q3 		$2K Hold
17
– – ﹤0.01% 76
2022
Q2 		$2K Hold
17
– – ﹤0.01% 67
2022
Q1 		$3K Buy
+17
New +$2.86K ﹤0.01% 69

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Davidson Capital Management's MRNA Position: Q2 2024 in Review

Davidson Capital Management sold out of Moderna (MRNA) in Q2 2024, closing a stake of 50 shares — an estimated $5.33K sold.

Davidson Capital Management first reported a position in MRNA in Q1 2022 and held it in 8 quarters. The position peaked at $5.33K in Q1 2024. 954 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Davidson Capital Management reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Davidson Capital Management sold 50 Moderna shares in Q2 2024, an estimated $5.33K.
  • Davidson Capital Management first reported a position in Moderna in Q1 2022 and held it in 8 quarters.
  • Davidson Capital Management's Moderna position peaked at $5.33K in Q1 2024.
  • 954 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Davidson Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.